Company Filing History:
2 out of 3,540 
1 out of 6 Years Active: 2014-2016
Title: George Lountos: Innovator in Hepatitis C Treatment
Introduction
George Lountos is a notable inventor based in Frederick, MD (US). He has made significant contributions to the field of medicine, particularly in the treatment of Hepatitis C Virus (HCV) infections. With a total of 2 patents, Lountos has demonstrated his commitment to advancing healthcare through innovative solutions.
Latest Patents
Lountos's latest patents include a method of treating HCV infection with a small molecule CHK2 inhibitor. This method involves providing a therapeutically effective amount of a compound to a patient in need, utilizing a specific formula that includes a heteroaryl group. Another significant patent is related to kinase inhibitors, which outlines compounds with a unique structure and their methods of use.
Career Highlights
Throughout his career, Lountos has worked with esteemed organizations, including the United States Department of Health and Human Services and Provid Pharmaceuticals Inc. His work has focused on developing effective treatments for viral infections, showcasing his dedication to public health.
Collaborations
Lountos has collaborated with notable individuals in his field, including David Waugh and Christopher Self. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
George Lountos is a distinguished inventor whose work in the treatment of Hepatitis C has the potential to impact many lives. His innovative patents and collaborations reflect his dedication to improving healthcare solutions.